copper peptide ghk-cu subcutaneous injection side effects Are GHK-Cu Injections Safe Enough?

The peptide does not appear to significantly alter IGF-1 levels, pose a risk for cancer progression, or induce insulin resistance

Finally, we compared our peptides with FOXO4-DRI peptide and found that, while FOXO4-DRI has minimal lytic activity in dividing cells, our peptides had 3-7 times higher senolytic activity (Figure 4f)

Just take a look at the following, all of which was hunted down and identified by the good folks at Suppversity in their article on BPC-157

The late responders are the set of people who get to the peak of their results in three to four months

subcutaneous or intramuscular." In plain terms, it's the administration code you bill when a provider or supervised clinical staff member gives a non-vaccine, non-chemotherapy drug by injection into the muscle or under the skin